3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Unknown
1
Recruiting
1
Not yet recruiting
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
7
Thymoma
1
Neoplasm Metastasis
1
Esophageal Neoplasms
1
Clinical Stage III Gastric Cancer AJCC v8
1
Carcinoma, Non-Small-Cell Lung
1
Advanced Gastric Cancer
1
Adenocarcinoma Of Esophagus
1
Adenocarcinoma
1
Interventions
Fluorouracil
5
Radiotherapy
3
Paclitaxel
3
Leucovorin
3
Endoscopy
3
Cisplatin
3
Oxaliplatin
2
Neoadjuvant Therapy
2
Endoscopy, Digestive System
2
Endoscopic Mucosal Resection
2
Carboplatin
2
tremelimumab
1
rucaparib
1
rubitecan
1
durvalumab
1
Taxes
1
Surveys and Questionnaires
1
Ramucirumab
1
Radiation
1
Positron Emission Tomography Computed Tomography
1
Nivolumab
1
Microarray Analysis
1
Magnetic Resonance Imaging
1
Irinotecan
1
High-Throughput Screening Assays
1
Genetic Linkage
1
Epirubicin
1
Dynamic Contrast Enhanced Magnetic Resonance Imaging
1
Drug Therapy
1
Docetaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Adenocarcinoma Of Esophagus
×
Ramucirumab
×
Clear all
NCT03995017
2023-02-01
RiME
University of Kansas Medical Center
Phase 1/2
Unknown
34 enrolled